Anzeige
Mehr »
Login
Sonntag, 20.06.2021 Börsentäglich über 12.000 News von 662 internationalen Medien
Diese POWER-AKTIE trotzt allem und steigt einfach weiter! Ausbruch unter hohem Volumen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCDR ISIN: US20451W1018 Ticker-Symbol: 5Y6 
Tradegate
18.06.21
18:27 Uhr
30,800 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
COMPASS PATHWAYS PLC ADR Chart 1 Jahr
5-Tage-Chart
COMPASS PATHWAYS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
30,00031,40018:04
30,30031,20018.06.

Aktuelle News zur COMPASS PATHWAYS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTURNAROUND & KURS-GEWINNE ...: Top-News und lukrative Einstiegskurse: Einführung eines hochmodernen therapeutischen Wirkstoff- Screenings!
04.06.Compass Pathways: Huge Growth Potential, But I'm Cautious24
03.06.COMPASS Pathfinder Ltd.: COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers313LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
► Artikel lesen
COMPASS PATHWAYS Aktie jetzt für 0€ handeln
26.05.Is Compass Pathways a Buy?41
18.05.Compass Pathways Offers Chance on Exploratory Mental Health Treatments18
13.05.COMPASS Pathways ADS reports Q1 results15
13.05.COMPASS Pathfinder Ltd.: COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021308Highlights: New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Two...
► Artikel lesen
13.05.COMPASS Pathways plc - 6-K, Report of foreign issuer6
06.05.COMPASS Pathfinder Ltd.: COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 202112
30.04.COMPASS Pathways raises $144M capital via equity offering19
30.04.COMPASS Pathfinder Ltd.: COMPASS Pathways announces pricing of public offering384London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based...
► Artikel lesen
27.04.COMPASS Pathways launches public offering15
27.04.COMPASS Pathfinder Ltd.: COMPASS Pathways launches proposed public offering407London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
► Artikel lesen
27.04.COMPASS Pathways plc - F-1, Registration statement for certain foreign private issuers2
26.04.The Shroom Boom Is Here. Buy CMPS Stock to Ride This Explosive Megatrend.21
15.04.COMPASS Pathways plc - 6-K, Report of foreign issuer16
09.04.COMPASS Pathfinder Ltd.: COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference340London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health...
► Artikel lesen
01.04.COMPASS Pathfinder Ltd.: COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors379COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK - 1 April 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care...
► Artikel lesen
26.03.Hut 8 Mining Corp: Hut 8 Mining buys $30M (U.S.) of Nvidia CMPs37
26.03.HUT 8 expands mining capacity with $30M NVIDIA CMPs purchase11
Seite:  Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
5,4,10